SNRNP27
gene geneOn this page
Also known as RY1U4/U6.U5-27K
Summary
SNRNP27 (small nuclear ribonucleoprotein U4/U6.U5 subunit 27, HGNC:30240) is a protein-coding gene on chromosome 2p13.3, encoding U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein (Q8WVK2). May play a role in mRNA splicing. It is a common-essential gene (DepMap: required in 99.7% of cancer cell lines).
This gene encodes a serine/arginine-rich (SR) protein. SR proteins play important roles in pre-mRNA splicing by facilitating the recognition and selection of splice sites. The encoded protein associates with the 25S U4/U6.U5 tri-snRNP, a major component of the U2-type spiceosome. The expression of this gene may be altered in cells infected with the human T-cell lymphotropic virus type 1 (HTLV-1) retrovirus. A pseudogene of this gene is located on the long arm of chromosome 5. Alternatively spliced transcript variants have been observed for this gene.
Source: NCBI Gene 11017 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 29 total
- Cancer dependency (DepMap): dependent in 99.7% of screened cell lines (common-essential)
- MANE Select transcript:
NM_006857
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30240 |
| Approved symbol | SNRNP27 |
| Name | small nuclear ribonucleoprotein U4/U6.U5 subunit 27 |
| Location | 2p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RY1, U4/U6.U5-27K |
| Ensembl gene | ENSG00000124380 |
| Ensembl biotype | protein_coding |
| OMIM | 619629 |
| Entrez | 11017 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000244227, ENST00000409116, ENST00000450162, ENST00000487029, ENST00000488986, ENST00000911721, ENST00000911722, ENST00000958235
RefSeq mRNA: 1 — MANE Select: NM_006857
NM_006857
CCDS: CCDS33219
Canonical transcript exons
ENST00000244227 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000846474 | 69896436 | 69896548 |
| ENSE00001006484 | 69904254 | 69905236 |
| ENSE00001006485 | 69895094 | 69895214 |
| ENSE00001129931 | 69893956 | 69894018 |
| ENSE00003482488 | 69897377 | 69897456 |
| ENSE00003676464 | 69903181 | 69903245 |
Expression profiles
Bgee: expression breadth ubiquitous, 298 present calls, max score 98.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 62.7804 / max 904.2777, expressed in 1824 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 20777 | 50.3882 | 1820 |
| 20778 | 12.3922 | 1796 |
Top tissues by expression
301 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 98.64 | gold quality |
| muscle of leg | UBERON:0001383 | 95.89 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 95.37 | gold quality |
| muscle organ | UBERON:0001630 | 95.24 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 95.24 | gold quality |
| sural nerve | UBERON:0015488 | 95.11 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 94.96 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.91 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.74 | gold quality |
| amygdala | UBERON:0001876 | 94.71 | gold quality |
| ventricular zone | UBERON:0003053 | 94.69 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.62 | gold quality |
| retina | UBERON:0000966 | 94.60 | gold quality |
| biceps brachii | UBERON:0001507 | 94.59 | gold quality |
| tibialis anterior | UBERON:0001385 | 94.39 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 94.36 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.29 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.28 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 94.20 | gold quality |
| heart right ventricle | UBERON:0002080 | 94.05 | gold quality |
| spinal cord | UBERON:0002240 | 94.00 | gold quality |
| hypothalamus | UBERON:0001898 | 93.87 | gold quality |
| superficial temporal artery | UBERON:0001614 | 93.82 | gold quality |
| deltoid | UBERON:0001476 | 93.75 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 93.71 | gold quality |
| islet of Langerhans | UBERON:0000006 | 93.53 | gold quality |
| cortical plate | UBERON:0005343 | 93.51 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 93.34 | gold quality |
| buccal mucosa cell | CL:0002336 | 93.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.80 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
65 targeting SNRNP27, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-6755-5P | 99.95 | 65.59 | 464 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-154-3P | 99.50 | 70.05 | 831 |
| HSA-MIR-487A-3P | 99.50 | 69.95 | 840 |
| HSA-MIR-409-3P | 99.50 | 66.33 | 1192 |
| HSA-MIR-217-5P | 99.49 | 69.93 | 1419 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 99.7% of screened cell lines, common-essential.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | snrnp27 | ENSDARG00000035625 |
| mus_musculus | Snrnp27 | ENSMUSG00000001158 |
| rattus_norvegicus | Snrnp27 | ENSRNOG00000065135 |
| rattus_norvegicus | LOC100910341 | ENSRNOG00000070440 |
| caenorhabditis_elegans | snrp-27 | WBGENE00011035 |
Protein
Protein identifiers
U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein — Q8WVK2 (reviewed: Q8WVK2)
Alternative names: Nucleic acid-binding protein RY-1, U4/U6.U5 tri-snRNP-associated 27 kDa protein, U4/U6.U5 tri-snRNP-associated protein 3
All UniProt accessions (4): A8K513, B8ZZ98, Q8WVK2, H0YBW5
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in mRNA splicing.
Subunit / interactions. Part of a tri-snRNP complex.
Subcellular location. Nucleus.
Post-translational modifications. Phosphorylated in vitro by snRNP-associated protein kinase.
Similarity. Belongs to the SNUT3 family.
RefSeq proteins (1): NP_006848* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013957 | SNRNP27 | Domain |
Pfam: PF08648
UniProt features (12 total): modified residue 5, compositionally biased region 3, sequence variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
10 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6QW6 | ELECTRON MICROSCOPY | 2.92 |
| 8H6E | ELECTRON MICROSCOPY | 3.2 |
| 8H6J | ELECTRON MICROSCOPY | 3.25 |
| 6QX9 | ELECTRON MICROSCOPY | 3.28 |
| 8QP8 | ELECTRON MICROSCOPY | 3.5 |
| 8QP9 | ELECTRON MICROSCOPY | 4.1 |
| 8QPK | ELECTRON MICROSCOPY | 4.2 |
| 8R0A | ELECTRON MICROSCOPY | 5.8 |
| 8R08 | ELECTRON MICROSCOPY | 6.1 |
| 8QXD | ELECTRON MICROSCOPY | 9.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WVK2-F1 | 59.22 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5): 61, 65, 111, 114, 132
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-72163 | mRNA Splicing - Major Pathway |
| R-HSA-72172 | mRNA Splicing |
| R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA |
| R-HSA-8953854 | Metabolism of RNA |
MSigDB gene sets: 144 (showing top):
HORIUCHI_WTAP_TARGETS_DN, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, MARTINEZ_RB1_TARGETS_DN, REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOBP_RNA_SPLICING, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, REACTOME_MRNA_SPLICING, WANG_CISPLATIN_RESPONSE_AND_XPC_DN, MARTINEZ_RB1_AND_TP53_TARGETS_UP, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY, REACTOME_METABOLISM_OF_RNA, GOCC_PRECATALYTIC_SPLICEOSOME
GO Biological Process (3): mRNA splicing, via spliceosome (GO:0000398), mRNA processing (GO:0006397), RNA splicing (GO:0008380)
GO Molecular Function (2): nucleic acid binding (GO:0003676), protein binding (GO:0005515)
GO Cellular Component (4): nucleus (GO:0005634), nucleoplasm (GO:0005654), spliceosomal complex (GO:0005681), U4/U6 x U5 tri-snRNP complex (GO:0046540)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| mRNA Splicing | 1 |
| Processing of Capped Intron-Containing Pre-mRNA | 1 |
| Metabolism of RNA | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA processing | 2 |
| binding | 2 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 |
| mRNA processing | 1 |
| mRNA metabolic process | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| nuclear protein-containing complex | 1 |
| ribonucleoprotein complex | 1 |
| U5 snRNP | 1 |
| U4/U6 snRNP | 1 |
| spliceosomal tri-snRNP complex | 1 |
Protein interactions and networks
STRING
1648 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SNRNP27 | USP39 | Q53GS9 | 940 |
| SNRNP27 | SNRNP70 | P08621 | 758 |
| SNRNP27 | GPATCH1 | Q9BRR8 | 487 |
| SNRNP27 | SART1 | O43290 | 478 |
| SNRNP27 | KCNJ5-AS1 | Q8TAV5 | 478 |
| SNRNP27 | LSM7 | Q9UK45 | 421 |
| SNRNP27 | HOATZ | Q6PI97 | 400 |
| SNRNP27 | CIRSR | Q86X95 | 373 |
| SNRNP27 | SRRM1 | Q8IYB3 | 373 |
| SNRNP27 | FAM13B | Q9NYF5 | 370 |
| SNRNP27 | CFAP92 | Q9ULG3 | 360 |
| SNRNP27 | RSRC1 | Q96IZ7 | 356 |
| SNRNP27 | EIF1AD | Q8N9N8 | 346 |
| SNRNP27 | ARRDC4 | Q8NCT1 | 340 |
| SNRNP27 | GPN3 | Q9UHW5 | 340 |
IntAct
86 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SNRPE | GEMIN2 | psi-mi:“MI:0914”(association) | 0.770 |
| SNRNP27 | SRPK2 | psi-mi:“MI:0915”(physical association) | 0.750 |
| SNRNP27 | SRPK2 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.750 |
| SRPK2 | SNRNP27 | psi-mi:“MI:0915”(physical association) | 0.750 |
| PRPF3 | PRPF4 | psi-mi:“MI:0914”(association) | 0.730 |
| SNRPG | GEMIN2 | psi-mi:“MI:0914”(association) | 0.710 |
| SNRPA1 | U2SURP | psi-mi:“MI:0914”(association) | 0.640 |
| SNRNP27 | UBA6 | psi-mi:“MI:0914”(association) | 0.530 |
| SNRPE | PRMT5 | psi-mi:“MI:0914”(association) | 0.530 |
| SNRPN | PRMT5 | psi-mi:“MI:0914”(association) | 0.530 |
| SNRPE | SNRPGP15 | psi-mi:“MI:0914”(association) | 0.530 |
| KIF2C | KIF2A | psi-mi:“MI:0914”(association) | 0.530 |
| SNRNP40 | AQR | psi-mi:“MI:0914”(association) | 0.530 |
| EZH1 | EPOP | psi-mi:“MI:0914”(association) | 0.530 |
| DRG1 | LRRC41 | psi-mi:“MI:0914”(association) | 0.530 |
| SNRNP27 | CHERP | psi-mi:“MI:0915”(physical association) | 0.510 |
| CHERP | SNRNP27 | psi-mi:“MI:0915”(physical association) | 0.510 |
| Prpf8 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| OTUB1 | psi-mi:“MI:0914”(association) | 0.350 | |
| ATL2 | ACRBP | psi-mi:“MI:0914”(association) | 0.350 |
| LAMB3 | MRPL58 | psi-mi:“MI:0914”(association) | 0.350 |
| SNRPGP15 | GEMIN2 | psi-mi:“MI:0914”(association) | 0.350 |
| LSM5 | LSM1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRPF3 | PRPF4 | psi-mi:“MI:0914”(association) | 0.350 |
| RBM42 | SART1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (270): SNRNP27 (Two-hybrid), SNRNP27 (Affinity Capture-MS), SNRNP27 (Affinity Capture-MS), ARGLU1 (Co-fractionation), SNRNP27 (Affinity Capture-MS), SNRNP27 (Affinity Capture-MS), SNRNP27 (Affinity Capture-MS), SNRNP27 (Affinity Capture-MS), RECQL (Affinity Capture-MS), SNRNP27 (Affinity Capture-MS), WDR5B (Affinity Capture-MS), C9orf89 (Affinity Capture-MS), EIF2A (Affinity Capture-MS), SBDS (Affinity Capture-MS), SNRNP27 (Affinity Capture-MS)
ESM2 similar proteins: A0JNI5, A2AJT4, A2AQ19, A4IFB1, B1H1X4, D3ZTQ1, O43290, P35269, Q05519, Q12872, Q13435, Q3THK3, Q3UJB0, Q3UQU0, Q3USH5, Q4V7C9, Q53F19, Q568R1, Q5EA53, Q5HZB6, Q5PQQ2, Q5R539, Q5RAD5, Q5XIW8, Q5ZM19, Q66I22, Q6AY96, Q6DDA4, Q6GLZ8, Q6INH5, Q6ZPZ3, Q8BZR9, Q8CFC7, Q8K194, Q8N2M8, Q8N5F7, Q8TF01, Q8VHI6, Q8WVK2, Q923D5
Diamond homologs: O74418, Q6DDA4, Q6DH74, Q6GLZ8, Q8K194, Q8WVK2
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SNRNP27 | “form complex” | “U4/U6.U5 snRNP complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 117 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| mRNA Splicing | 12 | 14.5× | 1e-08 |
| Processing of Capped Intron-Containing Pre-mRNA | 12 | 10.8× | 2e-07 |
| mRNA Splicing - Major Pathway | 18 | 10.8× | 3e-11 |
| CHD1 and CHD2 subfamily | 7 | 8.4× | 2e-03 |
| Transcriptional regulation of granulopoiesis | 6 | 8.3× | 7e-03 |
| Metabolism of RNA | 15 | 6.9× | 6e-07 |
| Signaling by Interleukins | 9 | 6.3× | 2e-03 |
| Dengue Virus-Host Interactions | 10 | 5.0× | 3e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| RNA splicing, via transesterification reactions | 6 | 33.7× | 6e-06 |
| spliceosomal complex assembly | 5 | 27.1× | 2e-04 |
| spliceosomal snRNP assembly | 5 | 26.2× | 2e-04 |
| mRNA splicing, via spliceosome | 15 | 12.4× | 9e-10 |
| RNA splicing | 15 | 11.9× | 9e-10 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
656 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:69894016:GGG:G | donor_gain | 1.0000 |
| 2:69894017:GGG:G | donor_gain | 1.0000 |
| 2:69896427:A:AG | acceptor_gain | 1.0000 |
| 2:69896428:A:G | acceptor_gain | 1.0000 |
| 2:69896432:TTAG:T | acceptor_loss | 1.0000 |
| 2:69896433:TAGAT:T | acceptor_loss | 1.0000 |
| 2:69896434:A:AG | acceptor_gain | 1.0000 |
| 2:69896434:AGATC:A | acceptor_loss | 1.0000 |
| 2:69896435:G:GA | acceptor_gain | 1.0000 |
| 2:69896545:ACTGG:A | donor_loss | 1.0000 |
| 2:69896546:CTGGT:C | donor_loss | 1.0000 |
| 2:69896547:TGGT:T | donor_loss | 1.0000 |
| 2:69896548:GGTAA:G | donor_loss | 1.0000 |
| 2:69896549:G:GG | donor_gain | 1.0000 |
| 2:69896549:G:T | donor_loss | 1.0000 |
| 2:69896550:T:A | donor_loss | 1.0000 |
| 2:69897373:GCAGA:G | acceptor_loss | 1.0000 |
| 2:69897374:CA:C | acceptor_loss | 1.0000 |
| 2:69897375:A:AG | acceptor_gain | 1.0000 |
| 2:69897375:AGAG:A | acceptor_gain | 1.0000 |
| 2:69897376:G:GG | acceptor_gain | 1.0000 |
| 2:69897376:GA:G | acceptor_gain | 1.0000 |
| 2:69897376:GAGG:G | acceptor_gain | 1.0000 |
| 2:69897376:GAGGA:G | acceptor_gain | 1.0000 |
| 2:69897452:CAAAA:C | donor_gain | 1.0000 |
| 2:69897453:AAAA:A | donor_gain | 1.0000 |
| 2:69897453:AAAAG:A | donor_loss | 1.0000 |
| 2:69897454:AAA:A | donor_gain | 1.0000 |
| 2:69897455:AA:A | donor_gain | 1.0000 |
| 2:69897455:AAGTA:A | donor_loss | 1.0000 |
AlphaMissense
997 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:69897431:G:A | G108E | 1.000 |
| 2:69903236:G:C | R135T | 1.000 |
| 2:69903236:G:T | R135M | 1.000 |
| 2:69903237:G:C | R135S | 1.000 |
| 2:69903237:G:T | R135S | 1.000 |
| 2:69903241:T:C | Y137H | 1.000 |
| 2:69903241:T:G | Y137D | 1.000 |
| 2:69903242:A:G | Y137C | 1.000 |
| 2:69903244:A:G | R138G | 1.000 |
| 2:69903244:A:T | R138W | 1.000 |
| 2:69903245:G:C | R138T | 1.000 |
| 2:69903245:G:T | R138M | 1.000 |
| 2:69904254:G:C | R138S | 1.000 |
| 2:69904254:G:T | R138S | 1.000 |
| 2:69904257:G:C | Q139H | 1.000 |
| 2:69904257:G:T | Q139H | 1.000 |
| 2:69904258:T:A | Y140N | 1.000 |
| 2:69904258:T:C | Y140H | 1.000 |
| 2:69904258:T:G | Y140D | 1.000 |
| 2:69904259:A:C | Y140S | 1.000 |
| 2:69904259:A:G | Y140C | 1.000 |
| 2:69904262:T:A | M141K | 1.000 |
| 2:69904262:T:C | M141T | 1.000 |
| 2:69904262:T:G | M141R | 1.000 |
| 2:69904263:G:A | M141I | 1.000 |
| 2:69904263:G:C | M141I | 1.000 |
| 2:69904263:G:T | M141I | 1.000 |
| 2:69904264:A:C | N142H | 1.000 |
| 2:69904264:A:G | N142D | 1.000 |
| 2:69904265:A:T | N142I | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000133120 (2:69903229 C>G,T), RS1000133988 (2:69891962 G>A), RS1000861754 (2:69896320 C>A,G), RS1001291079 (2:69895980 T>G), RS1002246113 (2:69894105 G>A), RS1002400806 (2:69901490 T>A), RS1002601600 (2:69894639 G>T), RS1002632852 (2:69902766 T>C), RS1002934507 (2:69901643 C>T), RS1003065434 (2:69897672 G>A,C), RS1003197625 (2:69892607 A>G), RS1003476571 (2:69900149 G>A), RS1003824286 (2:69904082 T>C), RS1003913538 (2:69893159 A>G), RS1004030016 (2:69896679 T>G)
Disease associations
OMIM: gene MIM:619629 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006061_105 | Atrial fibrillation | 6.000000e-19 |
| GCST009665_12 | Breast cancer | 4.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, increases expression | 2 |
| FR900359 | increases phosphorylation | 1 |
| avobenzone | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| yessotoxin | decreases expression | 1 |
| abrine | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Selenium | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Aflatoxin B1 | increases expression, increases methylation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.